Japanese CROs Seek Partnerships Abroad To Survive
This article was originally published in PharmAsia News
Japanese clinical trial companies are seeking affiliations with similar firms abroad to survive in what has become a highly competitive business. Some Japanese firms, such as Asklep, consider international cooperation as part of an effort by companies in many countries to obtain business beyond their own borders. Among Japanese firms joining forces with others are Asklep, with Qualitix Clinical Research of Taiwan, and with ties to German and Canadian firms, and Acronet, joined with another Taiwanese company that already has entry into the United States and Asian markets. (Click here for more - a subscription may be required
You may also be interested in...
Amgen and Mylan will face US Food and Drug Administration actions dates on two of their biosimilar candidates in December, while ANDA sponsors have date-certain launches for two generic products.
With the European Commission "carefully assessing" the judgment of Europe's highest court that CBD is not a narcotic, HBW Insight speaks to an expert in cannabis law about what is likely to happen next.
The UK has used a special legislative process to temporarily authorize the use of the BNT-162b2 vaccine, with the first 800,000 shots expected to be delivered within days.